Authors: Tong, AW Papayoti, MH Netto, G Armstrong, DT Ordonez, G Lawson, JM Stone, MJ

Citation: Aw. Tong et al., Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer, CLIN CANC R, 7(3), 2001, pp. 691-703

Authors: Tong, AW Seamour, B Chen, J Su, D Ordonez, G Frase, L Netto, G Stone, MJ

Citation: Aw. Tong et al., CD40 ligand-induced apoptosis is Fas-independent in human multiple myelomacells, LEUK LYMPH, 36(5-6), 2000, pp. 543-558

Authors: Zhang, YA Nemunaitis, J Scanlon, KJ Tong, AW

Citation: Ya. Zhang et al., Anti-tumorigenic effect of a K-ras ribozyme against human lung cancer cellline heterotransplants in nude mice, GENE THER, 7(23), 2000, pp. 2041-2050

Authors: Tong, AW Seamour, B Lawson, JM Ordonez, G Vukelja, S Hyman, W Richards, D Stein, L Maples, PB Nemunaitis, J

Citation: Aw. Tong et al., Cellular immune profile of patients with advanced cancer before and after taxane treatment, AM J CL ONC, 23(5), 2000, pp. 463-472

Authors: Zhang, YA Nemunaitis, J Tong, AW

Citation: Ya. Zhang et al., Anti-K-ras ribozyme adenoviral vector for gene therapy of non-small cell lung cancer, METH MOL M, 35, 2000, pp. 261-271

Authors: Greco, C Ameglio, F Alvino, F Mosiello, A Cianciulli, AM Venturo, I Del Monte, G Giampaolo, M Tong, AW Gandolfo, GM

Citation: C. Greco et al., Phenotypic and genotypic alterations characterize patients bearing plasma cell dyscrasias with a high M-component, CELL PROLIF, 32(4), 1999, pp. 231-238